Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction – JAMA - 2013
Brief Summary:
In patients with symptomatic HFpEF, sildenafil does not improve exercise capacity (measured by peak VO2) or clinical status at 24 weeks.Reference: http://www.ncbi.nlm.nih.gov/pubmed/23478662
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you